Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA.
EMBO Rep. 2023 Feb 6;24(2):e54925. doi: 10.15252/embr.202254925. Epub 2022 Nov 28.
Vault RNAs (vtRNAs) are small noncoding RNAs and highly expressed in many eukaryotes. Here, we identified vtRNA2-1 as a novel regulator of the intestinal barrier via interaction with RNA-binding protein HuR. Intestinal mucosal tissues from patients with inflammatory bowel diseases and from mice with colitis or sepsis express increased levels of vtRNAs relative to controls. Ectopically expressed vtRNA2-1 decreases the levels of intercellular junction (IJ) proteins claudin 1, occludin, and E-cadherin and causes intestinal epithelial barrier dysfunction in vitro, whereas vtRNA2-1 silencing promotes barrier function. Increased vtRNA2-1 also decreases IJs in intestinal organoid, inhibits epithelial renewal, and causes Paneth cell defects ex vivo. Elevating the levels of tissue vtRNA2-1 in the intestinal mucosa increases the vulnerability of the gut barrier to septic stress in mice. vtRNA2-1 interacts with HuR and prevents HuR binding to claudin 1 and occludin mRNAs, thus decreasing their translation. These results indicate that vtRNA2-1 impairs intestinal barrier function by repressing HuR-facilitated translation of claudin 1 and occludin.
Vault RNAs (vtRNAs) 是小的非编码 RNA,在许多真核生物中高度表达。在这里,我们通过与 RNA 结合蛋白 HuR 的相互作用,将 vtRNA2-1 鉴定为一种新型的肠道屏障调节剂。与对照组相比,炎症性肠病患者和结肠炎或败血症小鼠的肠道黏膜组织中表达的 vtRNA 水平增加。异位表达的 vtRNA2-1 降低细胞间连接 (IJ) 蛋白 Claudin 1、occludin 和 E-cadherin 的水平,并在体外引起肠道上皮屏障功能障碍,而 vtRNA2-1 沉默则促进屏障功能。增加的 vtRNA2-1 还减少了肠道类器官中的 IJ,抑制上皮更新,并导致体外潘氏细胞缺陷。肠道黏膜组织中组织 vtRNA2-1 水平的升高增加了肠道屏障对小鼠败血症应激的脆弱性。vtRNA2-1 与 HuR 相互作用并阻止 HuR 与 Claudin 1 和 occludin mRNA 结合,从而降低其翻译。这些结果表明,vtRNA2-1 通过抑制 HuR 促进 Claudin 1 和 occludin 的翻译来损害肠道屏障功能。